Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.516 CHF
200.43 M CHF
2.64 B CHF
212.74 M
About GETINGE AB SER. B
Sector
Industry
CEO
Mattias Sven Perjos
Website
Headquarters
Gothenburg
Founded
1990
ISIN
SE0000202624
FIGI
BBG006TLQ6P9
Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GTN is 15.465 CHF — it has decreased by −4.19% in the past 24 hours. Watch GETINGE AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange GETINGE AB stocks are traded under the ticker GTN.
GTN stock has fallen by −4.19% compared to the previous week, the month change is a −13.12% fall, over the last year GETINGE AB has showed a 2.30% increase.
We've gathered analysts' opinions on GETINGE AB future price: according to them, GTN price has a max estimate of 24.38 CHF and a min estimate of 14.63 CHF. Watch GTN chart and read a more detailed GETINGE AB stock forecast: see what analysts think of GETINGE AB and suggest that you do with its stocks.
GTN stock is 4.37% volatile and has beta coefficient of 0.78. Track GETINGE AB stock price on the chart and check out the list of the most volatile stocks — is GETINGE AB there?
Today GETINGE AB has the market capitalization of 4.14 B, it has decreased by −4.72% over the last week.
Yes, you can track GETINGE AB financials in yearly and quarterly reports right on TradingView.
GETINGE AB is going to release the next earnings report on Jan 28, 2025. Keep track of upcoming events with our Earnings Calendar.
GTN earnings for the last quarter are 0.19 CHF per share, whereas the estimation was 0.20 CHF resulting in a −8.00% surprise. The estimated earnings for the next quarter are 0.30 CHF per share. See more details about GETINGE AB earnings.
GETINGE AB revenue for the last quarter amounts to 653.59 M CHF, despite the estimated figure of 664.59 M CHF. In the next quarter, revenue is expected to reach 829.07 M CHF.
GTN net income for the last quarter is 166.10 K CHF, while the quarter before that showed 43.31 M CHF of net income which accounts for −99.62% change. Track more GETINGE AB financial stats to get the full picture.
Yes, GTN dividends are paid annually. The last dividend per share was 0.37 CHF. As of today, Dividend Yield (TTM)% is 2.32%. Tracking GETINGE AB dividends might help you take more informed decisions.
GETINGE AB dividend yield was 1.96% in 2023, and payout ratio reached 49.69%. The year before the numbers were 1.96% and 46.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 6, 2024, the company has 11.74 K employees. See our rating of the largest employees — is GETINGE AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GETINGE AB EBITDA is 480.60 M CHF, and current EBITDA margin is 18.56%. See more stats in GETINGE AB financial statements.
Like other stocks, GTN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GETINGE AB stock right from TradingView charts — choose your broker and connect to your account.